No evidence for the in vivo activity of aromatase-inhibiting flavonoids

Journal of Steroid Biochemistry and Molecular Biology

Volumn 78, Issue 3, 2001, Pages 231-239

  Saarinen, Niina ^a   Joshi, Suresh C ^a   Ahotupa, Markku ^a   Li, Xiangdong ^a   Ämmälä, Jenni ^a   Mäkelä, Sari ^a,b   Santti, Risto ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Aromatase; Diet; Estrogen; Flavonoid

Indexed keywords

6 HYDROXYFLAVONE; 7 HYDROXYFLAVONE; ACACETIN; ANDROSTENEDIONE; APIGENIN; AROMATASE; CHRYSIN; ESTRADIOL; FISETIN; FLAVONOID; GALANGIN; KAEMPFEROL; LUTEOLIN; NARINGENIN; QUERCETIN; TRITIUM;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CHORIOCARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET; DRUG ABSORPTION; DRUG BIOAVAILABILITY; ENZYME INHIBITION; FEMALE; GENETIC TRANSFECTION; HORMONE INHIBITION; HUMAN; IN VIVO STUDY; KIDNEY CELL; NONHUMAN; RAT; UTERUS GROWTH;

ANDROSTENEDIONE; ANIMALS; ANTIOXIDANTS; AROMATASE; AROMATASE INHIBITORS; BREAST NEOPLASMS; CELL LINE; ENZYME INHIBITORS; ESTRADIOL; FEMALE; FLAVONOIDS; HUMANS; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION; UTERUS;

EID: 0034786460     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(01)00098-X     Document Type: Article

References (42)

1. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer
2. Breast and prostate cancer: An analysis of common epidemiological, genetic, and biochemical features
3. Evidence of prenatal influences on breast cancer risk
4. Endogenous hormones as a major factor in human cancer
5. Aromatase inhibitors as potential cancer chemopreventives
6. Dietary factors and risk of breast cancer: Combined analysis of 12 case-control studies
7. Vegetables, fruit and phytoestrogens as preventive agents
8. Fibre and breast cancer
9. Phytoestrogens: Epidemiology and a possible role in cancer protection
10. Dietary phytoestrogens
11. Phytoestrogens
12. Dietary flavonoid and cancer prevention: Evidence and potential mechanism
13. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta
14. Inhibition of aromatase activity by flavonoids
15. Structural aspects of antioxidant activity of flavonoids
16. Lignans and flavonoids inhibit aromatase enzyme in human adipocytes
17. Flavonoid inhibition of aromatase enzyme activity in human preadipocytes
18. Aromatase inhibition by flavonoids
19. Aromatase inhibition by flavonoids
20. Inhibition of human estrogen synthetase (aromatase) by flavones
21. Estrogen-specific 17β-hydroxysteroid oxidoreductase type I (E.C. 1.1.1.62) as a possible target for the action of phytoestrogens
22. Inhibition of 17β-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells
23. Mechanisms for the impact of whole grain fodds on cancer risk
24. Aromatase in the human choriocarcinoma JEG-3: Inhibition by R76713 in cultured cells and in tumors grown in nude mice
25. Hormonal effects of MPV-2213ad, a new selective aromatase inhibitior in healthy male subjects. A phase I study
26. Reproductive tract dysfunction in aromatase over-expressing transgenic male mice maintaining elevated serum estradiol and low testosterone concentrations
27. Antioxidant properties of the triphenylethylene antiestrogen drug toremifene
28. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study
29. Structure-activity relationships for antioxidant activities of a series of flavonoids in liposomal system
30. Antioxidant and prooxidant behaviour of flavonoids: Structure-activity relationships
31. Structure-antioxidant activity relationships of flavonoids and phenolic acids
32. Flavonoids as antioxidant agents: Importance of their interaction with biomembranes
33. Estrogenic flavonoids: Structural requirements for biological activity
34. Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids
35. Hormone mimics and molecular fossils
36. Dietary intake and bioavailability of polyphenols
37. Estrogenic activity of flavonoids in mice. The importance of estrogen receptor distribution, metabolism and bioavailability
38. Flavanone absorbtion after naringin, hesperidin, and citrus administraion
39. Bioavailability of flavonoids
40. Effeects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: Results from an in vitro and a dietary supplement study
41. Effect of parsley (Petroselinum crispum) intake on urinary apigenin excretion, blood antioxidant enzymes and biomarkers for oxidative stress in humans
42. In vitro biotransformation of flavonoids by rat liver microsomes